MA45221A - Nouveaux composés antibactériens - Google Patents
Nouveaux composés antibactériensInfo
- Publication number
- MA45221A MA45221A MA045221A MA45221A MA45221A MA 45221 A MA45221 A MA 45221A MA 045221 A MA045221 A MA 045221A MA 45221 A MA45221 A MA 45221A MA 45221 A MA45221 A MA 45221A
- Authority
- MA
- Morocco
- Prior art keywords
- antibacterial compounds
- new antibacterial
- new
- compounds
- antibacterial
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16173550 | 2016-06-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA45221A true MA45221A (fr) | 2021-05-19 |
Family
ID=56116327
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA045221A MA45221A (fr) | 2016-06-08 | 2017-06-05 | Nouveaux composés antibactériens |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US10633366B2 (fr) |
| EP (2) | EP3468970A1 (fr) |
| JP (2) | JP2019517546A (fr) |
| KR (2) | KR20190019084A (fr) |
| CN (2) | CN109790157A (fr) |
| AR (2) | AR108777A1 (fr) |
| AU (2) | AU2017276626A1 (fr) |
| BR (2) | BR112018075334A2 (fr) |
| CA (2) | CA3025270A1 (fr) |
| CY (1) | CY1123194T1 (fr) |
| DK (1) | DK3468975T3 (fr) |
| EA (2) | EA201892822A1 (fr) |
| ES (1) | ES2802233T3 (fr) |
| HR (1) | HRP20200894T1 (fr) |
| HU (1) | HUE049547T2 (fr) |
| IL (2) | IL263285A (fr) |
| LT (1) | LT3468975T (fr) |
| MA (1) | MA45221A (fr) |
| MD (1) | MD3468975T2 (fr) |
| ME (1) | ME03738B (fr) |
| MX (2) | MX2018015126A (fr) |
| PL (1) | PL3468975T3 (fr) |
| PT (1) | PT3468975T (fr) |
| RS (1) | RS60511B1 (fr) |
| SG (2) | SG11201810389XA (fr) |
| SI (1) | SI3468975T1 (fr) |
| SM (1) | SMT202000335T1 (fr) |
| WO (2) | WO2017211759A1 (fr) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI3468975T1 (sl) * | 2016-06-08 | 2020-08-31 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Nove antibakterijske spojine |
| WO2021161148A1 (fr) | 2020-02-10 | 2021-08-19 | Virox Technologies Inc. | Compositions antimicrobiennes contenant de l'acide peroxyphthalique et/ou un sel de celui-ci |
| AU2021383832A1 (en) | 2020-11-23 | 2023-06-22 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| WO2022235605A1 (fr) | 2021-05-04 | 2022-11-10 | Enanta Pharmaceuticals, Inc. | Nouveaux agents antiviraux macrocycliques |
| CN113698412A (zh) * | 2021-09-01 | 2021-11-26 | 临沂大学 | 一种香豆素并[4,3-b]吡咯类衍生物及其合成方法和应用 |
| WO2023086400A1 (fr) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Nouveaux agents antiviraux dérivés de spiropyrrolidine |
| WO2023086352A1 (fr) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Nouveaux agents antiviraux dérivés de spiropyrrolidine |
| WO2023086350A1 (fr) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Agents antiviraux contenant des alcynes |
| WO2023107419A1 (fr) | 2021-12-08 | 2023-06-15 | Enanta Pharmaceuticals, Inc. | Composés spirocycliques saturés utilisés comme agents antiviraux |
| US12006291B2 (en) | 2022-01-11 | 2024-06-11 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of 4,6,7-trifluoro-1H-indole-2-carboxylic acid |
| WO2023196307A1 (fr) | 2022-04-05 | 2023-10-12 | Enanta Pharmaceuticals, Inc. | Nouveaux agents antiviraux dérivés de spiropyrrolidine |
| CN115850672B (zh) * | 2022-11-25 | 2024-07-19 | 浙江甬仑聚嘉新材料有限公司 | 一种液晶聚合物及其制备方法和应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2886570B2 (ja) | 1989-09-29 | 1999-04-26 | エーザイ株式会社 | 縮合ヘテロ環を有する化合物 |
| AU645681B2 (en) * | 1991-05-02 | 1994-01-20 | John Wyeth & Brother Limited | Piperazine derivatives |
| US5607936A (en) | 1994-09-30 | 1997-03-04 | Merck & Co., Inc. | Substituted aryl piperazines as neurokinin antagonists |
| FR2822154B1 (fr) | 2001-03-13 | 2005-10-21 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent |
| US6921821B2 (en) * | 2002-06-12 | 2005-07-26 | Abbott Laboratories | Antagonists of melanin concentrating hormone receptor |
| DE102004041163A1 (de) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| WO2006046552A1 (fr) * | 2004-10-27 | 2006-05-04 | Toyama Chemical Co., Ltd. | Nouveaux composés hétérocycliques azotés et sels desdits composés |
| CN101184487B (zh) | 2005-03-31 | 2010-11-03 | 詹森药业有限公司 | 作为抗菌剂的二环吡唑化合物 |
| KR20080016577A (ko) * | 2005-05-24 | 2008-02-21 | 아스트라제네카 아베 | 항균 활성을 갖는 아미노피페리딘 퀴놀린 및 이들의아자이소스테릭 유사체 |
| MY150958A (en) * | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
| WO2006137485A1 (fr) * | 2005-06-24 | 2006-12-28 | Toyama Chemical Co., Ltd. | Nouveau composé hétérocyclique azoté et sel de celui-ci |
| CN101346379A (zh) * | 2005-10-21 | 2009-01-14 | 葛兰素集团有限公司 | 用作抗菌剂的周环并合的三环化合物 |
| EP2481735A1 (fr) * | 2007-05-09 | 2012-08-01 | Pfizer Inc. | Dérivés hétérocycliques substitués et leur utilisation pharmaceutique et compositions |
| JP5620636B2 (ja) * | 2007-11-26 | 2014-11-05 | 富山化学工業株式会社 | 新規な複素環化合物またはその塩を含有する抗菌剤 |
| JP2011520944A (ja) * | 2008-05-23 | 2011-07-21 | グラクソ グループ リミテッド | 窒素含有三環式化合物および抗菌剤としてのその使用 |
| KR20110016947A (ko) | 2008-05-23 | 2011-02-18 | 글락소 그룹 리미티드 | 트리시클릭 질소 함유 화합물 및 항박테리아제로서의 그의 용도 |
| TW201022279A (en) * | 2008-11-14 | 2010-06-16 | Astrazeneca Ab | Chemical compounds |
| EP2379554B1 (fr) | 2009-01-15 | 2015-11-11 | Glaxo Group Limited | Composés naphthyridine-2(1h)-one utiles comme antibactériens |
| AU2010206161B2 (en) | 2009-01-21 | 2014-08-07 | Basilea Pharmaceutica Ag | Novel bicyclic antibiotics |
| US9156822B2 (en) | 2010-07-02 | 2015-10-13 | The University Of North Carolina At Chapel Hill | Functionally selective ligands of dopamine D2 receptors |
| WO2012117421A1 (fr) * | 2011-03-02 | 2012-09-07 | Orchid Research Laboratories Ltd | Inhibiteurs de l'histone désacétylase |
| JP2014518267A (ja) * | 2011-06-27 | 2014-07-28 | 杏林製薬株式会社 | 細菌感染症の治療のための架橋二環式化合物 |
| PH12014500831A1 (en) | 2011-11-08 | 2019-08-07 | Actelion Pharmaceuticalds Ltd | 2-oxo-oxazolidin-3,5-diyl antibiotic derivatives |
| WO2013080156A1 (fr) | 2011-11-30 | 2013-06-06 | Actelion Pharmaceuticals Ltd | Antibiotiques d'octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one 3,7-disubstituée |
| CN105218501A (zh) * | 2014-07-03 | 2016-01-06 | 南京大学 | 含哌嗪环的香豆素类衍生物及其制备与在抗菌药物中的应用 |
| AU2015304847B2 (en) * | 2014-08-22 | 2018-10-25 | Glaxosmithkline Intellectual Property Development Limited | Tricyclic nitrogen containing compounds for treating Neisseria gonorrhoea infection |
| MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
| MA41168A (fr) | 2014-12-17 | 2017-10-24 | Acraf | Nouveaux composés antibactériens |
| SI3468975T1 (sl) * | 2016-06-08 | 2020-08-31 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Nove antibakterijske spojine |
-
2017
- 2017-06-05 SI SI201730306T patent/SI3468975T1/sl unknown
- 2017-06-05 ES ES17732775T patent/ES2802233T3/es active Active
- 2017-06-05 ME MEP-2020-112A patent/ME03738B/fr unknown
- 2017-06-05 MX MX2018015126A patent/MX2018015126A/es unknown
- 2017-06-05 CN CN201780042649.1A patent/CN109790157A/zh active Pending
- 2017-06-05 AU AU2017276626A patent/AU2017276626A1/en not_active Abandoned
- 2017-06-05 MD MDE20190471T patent/MD3468975T2/ro not_active IP Right Cessation
- 2017-06-05 RS RS20200735A patent/RS60511B1/sr unknown
- 2017-06-05 MA MA045221A patent/MA45221A/fr unknown
- 2017-06-05 HR HRP20200894TT patent/HRP20200894T1/hr unknown
- 2017-06-05 CA CA3025270A patent/CA3025270A1/fr not_active Abandoned
- 2017-06-05 DK DK17732775.6T patent/DK3468975T3/da active
- 2017-06-05 BR BR112018075334-3A patent/BR112018075334A2/pt not_active IP Right Cessation
- 2017-06-05 BR BR112018075297-5A patent/BR112018075297A2/pt not_active IP Right Cessation
- 2017-06-05 SM SM20200335T patent/SMT202000335T1/it unknown
- 2017-06-05 KR KR1020187036946A patent/KR20190019084A/ko not_active Ceased
- 2017-06-05 AU AU2017276627A patent/AU2017276627A1/en not_active Abandoned
- 2017-06-05 WO PCT/EP2017/063600 patent/WO2017211759A1/fr not_active Ceased
- 2017-06-05 EA EA201892822A patent/EA201892822A1/ru unknown
- 2017-06-05 KR KR1020187036945A patent/KR20190019083A/ko not_active Ceased
- 2017-06-05 PT PT177327756T patent/PT3468975T/pt unknown
- 2017-06-05 WO PCT/EP2017/063601 patent/WO2017211760A1/fr not_active Ceased
- 2017-06-05 MX MX2018015125A patent/MX2018015125A/es unknown
- 2017-06-05 CN CN201780039687.1A patent/CN109415373A/zh active Pending
- 2017-06-05 US US16/307,410 patent/US10633366B2/en not_active Expired - Fee Related
- 2017-06-05 HU HUE17732775A patent/HUE049547T2/hu unknown
- 2017-06-05 SG SG11201810389XA patent/SG11201810389XA/en unknown
- 2017-06-05 JP JP2018564240A patent/JP2019517546A/ja active Pending
- 2017-06-05 LT LTEP17732775.6T patent/LT3468975T/lt unknown
- 2017-06-05 SG SG11201810352XA patent/SG11201810352XA/en unknown
- 2017-06-05 PL PL17732775T patent/PL3468975T3/pl unknown
- 2017-06-05 EA EA201892815A patent/EA201892815A1/ru unknown
- 2017-06-05 EP EP17727595.5A patent/EP3468970A1/fr not_active Withdrawn
- 2017-06-05 US US16/307,193 patent/US10640488B2/en not_active Expired - Fee Related
- 2017-06-05 EP EP17732775.6A patent/EP3468975B1/fr active Active
- 2017-06-05 JP JP2018564236A patent/JP2019517545A/ja active Pending
- 2017-06-05 CA CA3025624A patent/CA3025624A1/fr not_active Abandoned
- 2017-06-07 AR ARP170101554A patent/AR108777A1/es unknown
- 2017-06-07 AR ARP170101555A patent/AR108778A1/es unknown
-
2018
- 2018-11-26 IL IL263285A patent/IL263285A/en unknown
- 2018-11-26 IL IL263283A patent/IL263283A/en unknown
-
2020
- 2020-06-29 CY CY20201100597T patent/CY1123194T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA44233A (fr) | Nouveaux composés | |
| EP3720430A4 (fr) | Composés benzocarbonyle | |
| MA42293A (fr) | Composés antibactériens | |
| MA44050A (fr) | Nouveaux composés | |
| MA52489A (fr) | Nouveaux composés | |
| EP3691623A4 (fr) | Composés de benzosulfonyle | |
| EP3558322A4 (fr) | Composés benzyl-amide phosphodiamide antiviraux | |
| IL264458B (en) | Cannabis composition | |
| EP3532069A4 (fr) | Composés aryl-amide phosphodiamide antiviraux | |
| EP3474845A4 (fr) | Composés immunomodulateurs | |
| MA45221A (fr) | Nouveaux composés antibactériens | |
| ME03419B (fr) | Composés dihydroisoquinolinone substitués | |
| MA41614A (fr) | Composés antiviraux | |
| EP3445750A4 (fr) | Composés thérapeutiques | |
| MA45148A (fr) | Composés de carfilzomib pégylés | |
| MA50504A (fr) | Composés antibactériens | |
| EP3853210A4 (fr) | Composés antibactériens | |
| EP3464336A4 (fr) | Composés | |
| EP3728289A4 (fr) | Composés optimisés | |
| EP3458041A4 (fr) | Compositions antibactériennes | |
| EP3310352A4 (fr) | Composés cristallins | |
| MA53430A (fr) | Nouveaux composés | |
| MA49522A (fr) | Nouveaux composés de quinoléinone | |
| EP3713941A4 (fr) | Composés de pyrazolopyridinone | |
| MA51221A (fr) | Composés de pyrazolopyridinone |